(HALO) Halozyme Therapeutics - Performance 8.2% in 12m
HALO performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
43.48%
#10 in Peer-Group
Rel. Strength
53.24%
#3584 in Stock-Universe
Total Return 12m
8.20%
#55 in Peer-Group
Total Return 5y
110.73%
#13 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 13.8 |
| P/E Forward | 11.0 |
| High / Low | USD |
|---|---|
| 52 Week High | 70.14 USD |
| 52 Week Low | 42.57 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 75.49 |
| Buy/Sell Signal +-5 | -0.79 |
| Support / Resistance | Levels |
|---|---|
| Support | 54.0, 52.0, 48.8, 45.6 |
| Resistance | 61.0, 57.8 |
12m Total Return: HALO (8.2%) vs XBI (-11.1%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
1.02% | 61.8% | 74.7% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
6.89% | -8.76% | 155% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
1.19% | -6.24% | 38% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-2.29% | 26.9% | -2.56% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
7.48% | -8.9% | 5.85% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
11.5% | 27.6% | -6.21% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.47% | 46.2% | -8.05% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.64% | 26.9% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: HALO vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for HALO
| Total Return (including Dividends) | HALO | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 6.13% | 3.15% | 4.01% |
| 3 Months | -5.10% | 17.08% | 17.14% |
| 12 Months | 8.20% | -11.14% | 13.46% |
| 5 Years | 110.73% | -21.96% | 112.73% |
| Trend Score (consistency of price movement) | HALO | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 36.1% | 52.1% | 90.3% |
| 3 Months | -58.5% | 79.4% | 97.5% |
| 12 Months | 4.2% | -87.4% | 46.4% |
| 5 Years | 50.4% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th64.00 | 2.89% | 2.04% |
| 3 Month | %th18.50 | -18.94% | -18.99% |
| 12 Month | %th72.50 | 21.76% | -4.64% |
| 5 Years | %th95.00 | 170.02% | -0.94% |
FAQs
Does Halozyme Therapeutics (HALO) outperform the market?
Yes,
over the last 12 months HALO made 8.20%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.14%.
Over the last 3 months HALO made -5.10%, while XBI made 17.08%.
Performance Comparison HALO vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
HALO vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 4.9% | 2.1% | -2.4% | -5% |
| US NASDAQ 100 | QQQ | 5% | 1.9% | -4.4% | -5% |
| German DAX 40 | DAX | 4.6% | 4.9% | -14.5% | -22% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 3.7% | 1.6% | -6.8% | -11% |
| Hongkong Hang Seng | HSI | 4% | 3.3% | -24.4% | -27% |
| India NIFTY 50 | INDA | 6.3% | 6.9% | -2.8% | 11% |
| Brasil Bovespa | EWZ | 9.1% | 6.8% | -17.4% | 7% |
HALO vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 6.3% | 4.4% | -5.6% | -16% |
| Consumer Discretionary | XLY | 4% | 2.8% | 5.4% | -10% |
| Consumer Staples | XLP | 7% | 6.3% | -1.4% | 1% |
| Energy | XLE | 2% | 2% | 5.2% | 6% |
| Financial | XLF | 6.4% | 3.5% | -4.7% | -17% |
| Health Care | XLV | 4.8% | 6.1% | 9.2% | 15% |
| Industrial | XLI | 4.5% | 1.7% | -8.2% | -15% |
| Materials | XLB | 4.3% | 1.7% | -3% | 4% |
| Real Estate | XLRE | 5.2% | 6.3% | -0.8% | -0% |
| Technology | XLK | 5% | -0.5% | -7.5% | -3% |
| Utilities | XLU | 4.9% | 3.5% | -6.4% | -12% |
| Aerospace & Defense | XAR | 4.3% | -0.7% | -22.3% | -41% |
| Biotech | XBI | 1.3% | 3% | 7.9% | 19% |
| Homebuilder | XHB | 1.9% | -2.6% | 4.2% | 9% |
| Retail | XRT | 5% | 2.9% | 2.5% | 2% |
HALO vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 4.3% | 2.83% | 11.6% | 13% |
| Natural Gas | UNG | 6.7% | 12.6% | 23.7% | 10% |
| Gold | GLD | 4.8% | 5.9% | -20.2% | -30% |
| Silver | SLV | 0.6% | -0.2% | -24.4% | -14% |
| Copper | CPER | -5.4% | -8.8% | -21.9% | -15% |
HALO vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 5.8% | 6.2% | 3% | 13% |
| iShares High Yield Corp. Bond | HYG | 5.5% | 5% | 0.7% | -1% |